Publications
2023
-
C. Weng, Y. L. K. Tan, W. G. Koh, W. H. Ang*,
Harnessing Transition Metal Scaffolds for Targeted Antibacterial Therapy,
Angew. Chem. Int. Ed.,
2023,
62,
e202310040
-
C. Weng, H. Yang, B. S. Loh, M. W. Wong*, W. H. Ang*,
Targeting Pathogenic Formate-Dependent Bacteria with a Bioinspired Metallo–Nitroreductase Complex,
J. Am. Chem. Soc.,
2023,
145,
6453-6461
-
J. Arakelyan, D. A. Rusanov, M. R. Chang, A. V. Asaturova, G. S. Kireeva, M. Alshehri, W. H. Ang, M. V. Babak,
Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II,
Coord. Chem. Rev.,
2023,
475,
214899
-
M. R. Chang, D. A. Rusanov, J. Arakelyan, M. Alshehri, A. V. Asaturova, G. S. Kireeva, M. V. Babak, W. H. Ang,
Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I,
Coord. Chem. Rev.,
2023,
475,
214923
2022
-
I. Kuznetcova, F. Bacher, S. M., Alfadul, M. J. R. Tham MJR, W. H. Ang, M. V. Babak, P. Rapta, V. B. Arion VB,
Elucidation of Structure-Activity Relationships in Indolobenzazepine-Derived Ligands and Their Copper(II) Complexes: The Role of Key Structural Components and Insight into the Mechanism of Action,
Inorg. Chem.,
2022,
61,
10167-10181
-
S. Y. Lim, Z. E. Low, R. P. W. Tan, Z. C. Lim, W. H. Ang, T. Kubota, M. Yamanaka, S. Pang, E. Simsek, S. F. Y. Li,
Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models,
Metallomics,
2022,
14,
mfac085
-
J. H. R. Tan, W. H. Ang, M. L. Foo*,
CountQuest: A Card Game Played on Zoom for Revising Effective Atomic Number Concept,
J. Chem. Ed.,
2022,
99,
2425-2430
2021
-
C. Weng,* L. Shen, J. W. Teo, Z. C. Lim, B. S. Loh, and W. H. Ang*,
Targeted Antibacterial Strategy Based on Reactive Oxygen Species Generated from Dioxygen Reduction Using an Organoruthenium Complex,
JACS Au,
2021,
1,
1348-1354
-
M. V. Babak,* K. R. Chong, P. Rapta, M. Zannikou, H. M. Tang, L. Reichert. M. R. Chang, V. Kushnarev, P. Heffeter, S. M. Meier-Menches, Z. C. Lim, J. Y. Yap, A. Casini, I. V. Balyasnikova, W. H. Ang* ,
Interfering with Metabolic Profile of Triple-Negative Breast Cancer using Rationally-Designed Metformin Prodrugs,
Angew. Chem. Int. Ed.,
2021,
60,
13405-13413
-
J. X. Ong, H. V. Le, V. E. Y. Lee, W. H. Ang*,
A Cisplatin‐Selective Fluorescent Probe for Real‐Time Monitoring of Mitochondrial Platinum Accumulation in Living Cells,
Angew. Chem. Int. Ed.,
2021,
60,
9264-9269
-
V. E. Y. Lee, Z. C. Lim, S. L. Chew and W. H. Ang*,
Strategy for Traceless Codrug Delivery with Platinum(IV) Prodrug Complexes Using Self-Immolative Linkers,
Inorg. Chem.,
2021,
60,
1823–1831
2020
-
G. Kim, H. L. Tan, R. Sundar, B. Lieske, C. E. Chee, J. Ho, A. Shabbir, M. V. Babak, W. H. Ang, B. C. Goh, W. P. Yong, L. Wang, J. B. Y. So,
PIPAC-OX: A Phase I study of Oxaliplatin-based Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Peritoneal Metastases,
Clin. Cancer Res.,
2020,
27,
1875
-
W. H. Ang,* B. Xing*,
AsBIC-9: The 9th Asian Biological Inorganic Chemistry Conference: Overview,
J. Inorg. Biochem.,
2020,
202,
1
-
D. Darwan, K. R. G. Lim, H. Wijaya, Z. C. Lim, T. Wang, W. H. Ang, Z.‐K. Tan.*,
Deep Fluorescence Imaging by Laser‐Scanning Excitation and Artificial Neural Network Processing.,
Adv. Optic. Mater.,
2020,
9,
2000390
-
K. R. G. Lim, D. Darwan, H. Wijaya, Z. C. Lim, J. Shanmugam, T. Wang, L. J. Lim, W. H. Ang, Z.‐K. Tan* ,
High Quantum Yield Water‐Dispersed Near‐Infrared In(Zn)As–In(Zn)P–GaP–ZnS Quantum Dots with Robust Stability for Bioimaging,
Adv. Mater. Interfaces,
2020,
7,
2000920
-
K. Ohui, I. Stepanenko, I. Besleaga, M. V. Babak, R. Stafi, D. Darvasiova, G. Giester, V. Pósa, E. A. Enyedy, D. Vegh, P. Rapta, W. H. Ang, A. Popović-Bijelić, V. B. Arion.*,
Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells,
Biomolecules,
2020,
10,
1336
-
B. S. Loh, W. H Ang*,
“Illuminating” Echinocandins’ Mechanism of Action,
ACS Cent. Sci.,
2020,
6,
1651-1653
-
M. J. R. Tham, M. V. Babak,* and W. H. Ang.*,
PlatinER: A Highly Potent Anticancer Platinum(II) Complex that Induces Endoplasmic Reticulum Stress Driven Immunogenic Cell Death,
Angew. Chem. Int. Ed.,
2020,
59,
19070-19078
-
J. X. Ong, W. H. Ang*,
Development of a Pre‐assembled Through‐Bond Energy Transfer (TBET) Fluorescent Probe for Ratiometric Sensing of Anticancer Platinum(ll) Complexes,
Chem. Asia. J.,
2020,
15,
1449-1455
-
C. Weng, L. Shen, W. H. Ang*,
Harnessing Endogenous Formate for Antibacterial Prodrug Activation by in cellulo Ruthenium-Mediated Transfer Hydrogenation Reaction,
Angew. Chem. Int. Ed.,
2020,
59,
9314-9318
-
H. V. Le, M. Babak, M. A. Ehsan, M. Altaf, L. Reichert, A. L. Gushchin, W. H. Ang,* A. A. Isab*,
Highly cytotoxic gold(I)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cells,
Dalton Trans,
2020,
49,
7355-7363
2019
-
A. De Luca, L. J. Parker, W. H. Ang, C. Rodolfo, V. Gabbarini, N. C. Hancock, F. Palone, A. P. Mazzetti, L. Menin, C. J. Morton, M. W. Parker,* M. Lo Bello,* and P. J. Dyson*,
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1,
Proc. Natl. Acad. Sci. U. S. A.,
2019,
116,
13943-13951
-
V. E. Y. Lee, C. F. Chin and W. H. Ang*,
Design and investigation of photoactivatable platinum(IV) prodrug complexes of cisplatin,
Dalton Trans.,
2019,
48,
7388-7393
-
M. V. Babak, Y. Zhi, B. Czarny, T. B. Toh, L. Hooi, E. K.-H. Chow, W. H. Ang,* D. Gibson,* and G. Pastorin*,
Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity (VIP),
Angew. Chem. Int. Ed.,
2019,
58,
8109-8114
-
J. X. Ong, C. S. Q. Lim, H. V. Le, and W. H. Ang*,
A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes,
Angew. Chem. Int. Ed.,
2019,
58,
164-167
2018
-
E. Orlowska, M. V. Babak, O. Dömötör, E. A. Enyedy, P. Rapta, M. Zalibera, L. Bučinský, M. Malček, C. Govind, V. Karunakaran, Y. C. S. Farid, T. E. McDonnell, D. Luneau, D. Schaniel, W. H. Ang, and V. A. Arion*,
NO Releasing and Anticancer Properties of Octahedral Ruthenium− Nitrosyl Complexes with Equatorial 1H‑Indazole Ligands,
Inorg. Chem.,
2018,
57,
10702-10717
-
S. De, M. V. Babak, M. J. Helsey, W. H. Ang,* and N. Yan*,
Designed Precursor for the Controlled Synthesis of Highly Active Atomic and Sub-nanometric Platinum Catalysts on Mesoporous Silica,
Chem. Asia J.,
2018,
13,
1053-1059
-
J. X. Ong, V. Y. T. Pang, L. M. Tng,and W. H. Ang*,
Pre-Assembled Coumarin–Rhodamine Scaffold for Ratiometric Sensing of Nitric Oxide and Hypochlorite,
Chem. Eur. J.,
2018,
24,
1870-1876
-
K. G, Z, Lee, M. V. Babak, A. Weiss, P. J. Dyson, P. Nowak-Sliwinska,* D. Montagner,* and W. H. Ang*,
Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug,
Chemmedchem,
2018,
13,
1210-1217
-
M. V. Babak* and W. H. Ang*,
Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy (Book Chapter),
Metal Ions in Life Sciences,
2018,
18,
171-194
-
M. J. Chow,* M. V. Babak, K. W. Tan, M. C. Cheong, G. Pastorin, C. Gaiddon and W. H. Ang*,
Induction of the Endoplasmic Reticulum Stress Pathway by Highly Cytotoxic Organoruthenium Schiff-Base Complexes,
Mol. Pharmaceutics,
2018,
15,
3020-3031
2017
-
M.J. Chow* and W.H. Ang*,
Organoruthenium(II)-Arene Complexes: Structural Building Blocks for Anticancer Drug Discovery (Book Chapter),
Inorganic and Organometallic Transition Metal Complexes with Biological Molecules and Living Cells,
2017,
117-146
-
S. Q. Yap, C. F. Chin, A. H. T. Thng, Y. Y. Pang, H. K. Ho,* and W. H. Ang*,
Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure–Activity Relationship and Application as Orally Available Prodrugs (VIP),
ChemMedChem,
2017,
4,
300-311
-
M. J. Chow, M. Alfiean, G. Pastorin, C. Gaiddon and W. H. Ang*,
Apoptosis-independent organoruthenium anticancer complexes that overcome multidrug resistance: self-assembly and phenotypic screening strategies ,
Chem. Sci.,
2017,
8,
3641-3649
-
A. Sîrbu, O. Palamarciuc, M. V. Babak,* J. M. Lim, K. Ohui, E. A. Enyedy, S. Shova, D. Darvasiová, P. Rapta, W. H. Ang,* and V. B. Arion* ,
Copper(II) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells,
Dalton Trans.,
2017,
46,
3833-3847
2016
-
M. J. Chow, M. V. Babak, D. Y. Q. Wong, G. Pastorin, C. Gaiddon,* W. H. Ang*,
Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Schiff-base Complexes,
Mol. Pharmaceutics,
2016,
13,
2543–2554
-
M. J. Chow, C. Licona, G. Pastorin, G. Mellitzer, W. H. Ang,* and C. Gaiddon*,
Structural tuning of organoruthenium compounds allows oxidative switch to control ER stress pathways and bypass multidrug resistance,
Chem. Sci.,
2016,
7,
4117-4124
2015
-
J. X. Ong, J. Y. Yap, S. Q. Yap, W. H. Ang*,
Structure–Activity Relationship Studies on Rhodamine B-based Fluorogenic Probes and Their Activation by Anticancer Platinum(II) Compounds,
J. Inorg. Biochem.,
2015,
153,
272-278
-
X. Bi, G. Adriani, Y. Xu, S. Chakrabortty, G. Pastorin, H. K. Ho, W. H. Ang* and Y. Chan*,
Gene Detection in Complex Biological Media Using Semiconductor Nanorods within an Integrated Microfluidic Device,
Anal. Chem.,
2015,
87,
10292-10298
-
E. Y. D. Chua, G. E. Davey, C. F. Chin, P. Dröge, W. H. Ang* and C. A. Davey*,
Stereochemical Control of Nucleosome Targeting by Platinum-Intercalator Antitumour Agents,
Nucleic Acid Res. ,
2015,
43,
5284-5296
-
S. L. Yoong, W. L. Lau, A. Y. Liu, D. Prendergast, H. K. Ho, V. C. K. Yu, C. Lee, W. H. Ang*, G. Pastorin*,
Mitochondria-acting hexokinase II peptides carried by short-length carbon nanotubes with increased cellular uptake, endosomal evasion, and enhanced bioactivity against cancer cells,
Nanoscale,
2015,
7,
13907-13917
-
D. Y. Q. Wong, W. W. F. Ong, W. H. Ang*,
Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes (VIP),
Angew. Chem. Int. Ed. ,
2015,
54,
6483-6487
-
D. Y. Q. Wong, J. H. Lim, W. H. Ang*,
Induction of Targeted Necrosis with HER2-targeted Platinum(IV) Anticancer Prodrugs,
Chem. Sci.,
2015,
6,
3051-3056
-
J. X. Ong, S. Q. Yap, D. Y. Q. Wong, C. F. Chin, W. H. Ang*,
Platinum(IV) Carboxylate Prodrug Complexes as Versatile Platforms for Targeted Chemotherapy (Special Issue),
Chimia,
2015,
69,
100-103
-
L. Muzi, C. Ménard-Moyon, J. Russier, J. Li, C. F. Chin, W. H. Ang, G. Pastorin,* G. Risuleo*, A. Bianco*,
Diameter-Dependent Release of a Cisplatin Pro-Drug from Small and Large Functionalized Carbon Nanotubes,
Nanoscale,
2015,
7,
5383-5394
2014
-
Z. Tay, S. H. Koo, T. T. T. Nguyen, T. S. Tan, M. L. Chen, C. F. Chin, K. K. Lim, W. H. Ang, B. H. Bay, E. J. D. Lee, E. S. Chen*,
P-glycoprotein and Vacuolar ATPase Synergistically Confer Anthracycline Resistance to Fission Yeast and Human Cells,
Curr. Med. Chem. ,
2014,
21,
251-260
-
Z. Adhireksan, G. E. Davey, P. Campomanes, M. Groessl, C. M. Clavel, H. Yu, A. A. Nazarov, C. H. F. Yeo, W. H. Ang, P. Dröge, U. Rothlisberger, P. J. Dyson and C. A. Davey*,
Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity,
Nat. Commun.,
2014,
5,
3462
-
M. J. Chow, C. Licona, D. Y. Q. Wong, G. Pastorin, C. Gaiddon, W. H. Ang*,
Discovery and Investigation of Anticancer Ruthenium Arene Schiff-Base Complexes via Water-Promoted Combinatorial Three-Component Assembly,
J. Med. Chem.,
2014,
57,
6043-6059
-
D. Y. Q. Wong, C. H. F. Yeo, and W. H. Ang*,
Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents,
Angew. Chem. Int. Ed.,
2014,
26,
6752-6756
-
J. Li, A. Pant, C. F. Chin, W. H. Ang*, C. Ménard-Moyon, T. R. Nayak, D. Gibson, S. Ramaprabhu, T. Panczyk, A. Bianco*, G. Pastorin*,
In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes,
Nanomedicine: Nanotechnology, Biology and Medicine,
2014,
10,
1465-1475
-
C. F. Chin,S. Q. Yap, J. Li, G. Pastorin*, and W. H. Ang* ,
Ratiometric Delivery of Cisplatin and Doxorubicin using Tumour-Targeting Carbon-Nanotubes Entrapping Platinum(IV) Prodrugs ,
Chem. Sci,
2014,
5,
2265-2270
-
S. L. Yoong, B. S. Wong, Q. L. Zhou, C. F. Chin, J. Li, T. Venkatesan, H. K. Ho, V. Yu, W. H. Ang*, and G. Pastorin*,
Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin,
Biomaterials,
2014,
35,
748-753
2013
-
T. Panczyk,* A. Jagusiak, G. Pastorin, W. H. Ang, J. Narkiewicz-Michalek ,
Molecular Dynamics Study of Cisplatin Release from Carbon Nanotubes Capped by Magnetic Nanoparticles,
J. Phys. Chem. C,
2013,
117,
17327-17336
-
B. S. Wong*, S. L. Yoong, A. Jagusiak, T. Panczyk, H. K. Ho, W. H. Ang, G. Pastorin*,
Carbon nanotubes for delivery of small molecule drugs,
Adv. Drug Deliv. Rev.,
2013,
15,
1964-2015
-
D. Montagner, S. Q. Yap, and W. H. Ang*,
A Fluorescent Probe for Investigating the Activation of Anticancer Platinum(IV) Prodrugs Based on the Cisplatin Scaffold,
Angew. Chem. Int. Ed.,
2013,
52,
11785-11789
-
P. Paira, M. J. Chow, G. Venkatesan, V. K. Kosaraju, S. L. Cheong, K.-N. Klotz, W. H. Ang*, G. Pastorin*,
Organoruthenium Antagonists of Human A3 Adenosine Receptors,
Chem. Eur. J.,
2013,
19,
8321-8330
2012
-
C. F. Chin, Q. Tian, M. I. Setyawati, W. Fang, E. S. Q. Tan, D. T. Leong, W. H. Ang*,
Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation,
J. Med. Chem.,
2012,
55,
7571-7582
-
A. Astarina, M. J. Chow, W. H. Ang*,
Transcription Inhibition by Organometallic Ruthenium–Arene Anticancer Complexes in Live Mammalian Cells,
Aust. J. Chem.,
2012,
65,
1271-1276
-
Q. Tian, W. Wong, Y. Xu, Y. Chan, H. K. Ho, G. Pastorin, W. H. Ang*,
Immobilisation of quantum dots by bio-orthogonal PCR amplification and labelling for direct gene detection and quantitation,
Chem. Commun.,
2012,
48,
5467-5469
-
J. Li, S. Q. Yap, C. F. Chin, G. Pastorin*, W. H. Ang*,
Platinum(IV) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversal,
Chem. Sci.,
2012,
3,
2083-2087
-
A. A. Nazarov, J. Risse, W. H. Ang, F. Schmitt, O. Zava, A. Ruggi, M. Groessl, R. Scopelitti, L. Juillerat-Jeanneret, C. G. Hartinger, P. J. Dyson,
Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds,
Inorg. Chem.,
2012,
51,
3633-3639
-
D. Y. Q. Wong, J. Y. Lau, W. H. Ang*,
Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum(IV) prodrugs,
Dalton Trans.,
2012,
41,
6104-6111
-
J. X. Ong, C. W. Yap, W. H. Ang*,
Rational Design of Selective Organoruthenium Inhibitors of Protein Tyrosine Phosphatase 1B,
Inorg. Chem.,
2012,
51,
12483-12492
2011
-
Y. Ren*, P. Priyankar, T. P. Nayak, W. H. Ang, G. Pastorin*,
Synthesis of fullerene@gold core–shell nanostructures,
Chem. Commun.,
2011,
74,
7710-7712
-
Y. Q. Tan, P. J. Dyson, W. H. Ang*,
Acetal-Functionalized RAPTA Complexes for Conjugation and Labeling,
Organometallics,
2011,
30,
5965-5971
-
J. Li, S. Q. Yap, S. L. Yoong, T. R. Nayak, G. W. Chandra, W. H. Ang, T. Panczyk, S. Ramaprabhu, S. K. Vashist, F.-S. Sheu, A. Tan, G. Pastorin*,
Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin,
Carbon,
2011,
50,
1625-1634
-
W. H. Ang, A. Casini, G. Sava, P. Dyson*,
Organometallic Ruthenium-Based Antitumor Compounds with Novel Modes of Action,
J. Organomet. Chem.,
2011,
696,
989-998
-
C. F. Chin, D. Y. Q. Wong, R. Jothibasu, W. H. Ang*,
Platinum(IV) anticancer complex with novel modes of activity,
Curr. Top. Med. Chem.,
2011,
11,
2602-2612
-
G. Zhu, M. Myint, W. H. Ang, L. Song, S. J. Lippard*,
Monofunctional Platinum–DNA Adducts Are Strong Inhibitors of Transcription and Substrates for Nucleotide Excision Repair in Live Mammalian Cells,
Cancer Res.,
2011,
72,
790-800
-
K. Johansson, M. Ito, C. M. S. Schophuizen, S. Matthew, V. Heuser-Dahlström, J. Zhang, M. Shimoji, W. H. Ang, P. Dyson, A. Shibata, S. Shuto, Y. Ito, H. Abe, R. Morgenstern*,
Characterization of new potential anti-cancer drugs designed to overcome glutathione transferase mediated resistance,
Mol. Pharmacol.,
2011,
8,
1698-1708
-
N. Graf, W. H. Ang, G. Zhu, M. Myint, S. J. Lippard*,
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity,
ChemBioChem,
2011,
12,
1115-1123
-
L. J. Parker, L. C. Italiano, C. J. Morton, N. C. Hancock, D. B. Ascher, J. B. Aitken, H. H. Harris, P. Campomanes, U. Rothlisberger, A. De Luca, M. Lo Bello, W. H. Ang, P. J. Dyson, M. W. Parker*,
Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation,
Chem. Eur. J.,
2011,
17,
7806-7816
2010
-
Z. Fei, D. Zhu, X. Yang,L. Meng, Q. Lu, W. H. Ang, R. Scopelliti, C. Hartinger, and P. J. Dyson,
An Internal Fluorescent Probe Based on Anthracene to Evaluate Cation–Anion Interactions in Imidazolium Salts,
Chem. Eur. J.,
2010,
16,
6473-6481
-
W. H. Ang, MyatNoeZin Myint, S. J. Lippard*,
Transcription inhibition by platinum DNA cross-links in live mammalian cells,
J. Am. Chem. Soc.,
2010,
132,
7429-7435
2009
-
W. H. Ang, R. L. Cordiner, A. F. Hill, T. L. Perry, J. Wagler,
Reactions of [Ru(CO)2(PPh3)3] with Alkynylphosphonium Salts: A Phosphinoallene Complex,
Organometallics,
2009,
28,
5568-5574
-
W. H. Ang, L. J. Parker, A. De Luca, L. Juillerat-Jeanneret, C. J. Morton, M. Lo Bello, M. W. Parker, Paul J. Dyson*,
Rational Design of an Organometallic Glutathione Transferase Inhibitor,
Angew. Chem. Int. Ed. Engl.,
2009,
48,
3854-3857
-
A. D. Phillips, Z. Fei, W. H. Ang, R. Scopelliti, P. J. Dyson,
A Crystallographic Story of Snakes and Ladders: Encapsulated Water Polymers and Rigid Metal Complexes Based on Mono-N-substituted Carboxylate 4,4′-Bipyridine,
Crystal Grow. Des,
2009,
9,
1966-1978
-
W. H. Ang, Z. Grote, R. Scopelliti, L. Juillerat-Jeanneret, K. Severin, P. J. Dyson*,
Organometallic complexes that interconvert between trimeric and monomeric structures as a function of pH and their effect on human cancer and fibroblast cells,
J. Organomet. Chem.,
2009,
694,
968-972
-
W. H. Ang, S. J. Lippard*,
Functional consequence of plasmid DNA modified site-specifically with 7-deaza-deoxyadenosine at a single, programmable site,
Chem. Commun.,
2009,
5820-5822
-
W. H. Ang, W. W. Brown, S. J. Lippard*,
Preparation of platinated mammalian expression vectors incorporating site-specifically platinated-DNA lesions,
Bioconjugate Chem.,
2009,
20,
1058-1063
2008
-
X. Yang, Z. Fei, D. Zhao, W. H. Ang, Y. Li, P. J. Dyson,
Palladium Nanoparticles Stabilized by an Ionic Polymer and Ionic Liquid: A Versatile System for C−C Cross-Coupling Reactions,
Inorg. Chem.,
2008,
47,
3292-3297
-
A. Mathieu, B. Therrien, G. Süss-Fink, P. Stepnicka, W. H. Ang, P. J. Dyson*,
Ferrocenoyl Pyridine Arene Ruthenium Complexes with Anticancer Properties: Synthesis, Structure, Electrochemistry, and Cytotoxicity,
Inorg. Chem.,
2008,
47,
578-583
-
F. Durap, N. Biricik, B. Gümgüm, S. Özkar, W. H. Ang, Z. Fei, R. Scopelliti,
Synthesis and characterizations of N,N-bis(diphenylphosphino)ethylaniline derivatives and X-ray crystal structure of palladium (II), platinum (II) complexes,
Polyhedron,
2008,
27,
196-202
-
F. Schmitt, P. Govindaswamy, G. Süss-Fink, W. H. Ang, P. J. Dyson, L. Juillerat-Jeanneret*, B. Therrien*,
Ruthenium-porphyrin compounds for photodynamic therapy of cancer,
J. Med. Chem.,
2008,
51,
1811-1816
-
N. Biricik, F. Durap, C. Kayan, B. Gümgüm, N. Gürbüz, I. Özdemir, W. H. Ang, Z. Fei, P. J. Dyson,
Synthesis of new aminophosphine complexes and their catalytic activities in C–C coupling reactions,
Organometallic Chem.,
2008,
16,
2693-2699
2007
-
W. H. Ang*, A. De Luca, C. Chapuis-Bernasconi, L. Juillerat-Jeanneret, M. Lo Bello*,
Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs,
ChemMedChem,
2007,
2,
1799-1806
-
D. Zhao, Z. Fei, D. Pieraccini, W. H. Ang, T. J. Geldbach, R. Scopelliti, C. Chiappe, P. J. Dyson,
Development of Nitrile-Functionalized Ionic Liquids for C−C Coupling Reactions: Implication of Carbene and Nanoparticle Catalysts,
Organometallics,
2007,
26,
1588-1598
-
B. Therrien, W. H. Ang, F. Chérioux, L. Vieille-Petit, L. Juillerat-Jeanneret, G. Süss-Fink*, P. J. Dyson*,
Remarkable anticancer activity of triruthenium-arene clusters compared to tetraruthenium-arene clusters,
J. Cluster Sci.,
2007,
18,
741-752
-
D. Zhao, Z. Fei, W. H. Ang, R. Scopelliti, P. J. Dyson,
Thiocyanate Functionalised Ionic Liquids: Synthesis, Characterisation and Reactivity,
Eur. J. Inorg. Chem.,
2007,
2,
279-284
-
A. Casini, G. Mastrobuoni, W. H. Ang, C. Gabbiani, G. Pieraccini, G. Moneti, P. J. Dyson*, L. Messori*,
ESI-MS characterization of protein adducts of anticancer ruthenium(II)-arene PTA (RAPTA) complexes,
ChemMedChem,
2007,
2,
631-635
-
D. Zhao, Z. Fei, W. H. Ang, P. J. Dyson,
Sulfonium-based Ionic Liquids Incorporating the Allyl Functionality,
Int. J. Mol. Sci.,
2007,
8,
304-315
-
W. H. Ang, E. Daldini, L. Juillerat-Jeanneret, P. J. Dyson*,
Strategy to tether organometallic ruthenium-arene anti-cancer compounds to recombinant human serum albumin,
Inorg. Chem.,
2007,
46,
9048-9050
-
W. H. Ang*,
Development of organometallic ruthenium(II) anticancer (RAPTA) drugs -Invited Paper-,
Chimia,
2007,
61,
140-142
-
Z. Fei, W. H. Ang, D. Zhao, R. Scopelliti, E. E. Zvereva, S. A. Katsyuba, P. J. Dyson,
Revisiting Ether-Derivatized Imidazolium-Based Ionic Liquids,
J. Phys. Chem. B.,
2007,
111,
10095-10108
-
C. Hartinger*, W. H. Ang, A. Casini, L. Messori, B. K. Keppler, P. J. Dyson,
Mass spectrometric analysis of ubiquitin-platinum complex interaction in leading anticancer drugs: MALDI versus ESI,
J. Anal. At. Spec.,
2007,
22,
960-967
-
C. A. Vock, W. H. Ang, C. Scolaro, L. Juillerat-Jeanneret*, G. Sava, P. J. Dyson*,
Synthesis, characterisation and in vitro evaluation of novel ruthenium(II) η6-arene complexes with MDR modulators as ligands,
J. Med. Chem.,
2007,
50,
2166 -2175
-
B. Gümgüm, N. Biricik, F. Durap, I. Özdemir, N. Gürbüz, W. H. Ang, P. J. Dyson,
Application of N,N-bis(diphenylphosphino)aniline palladium(II) complexes as pre-catalysts in Heck coupling reactions,
Appl. Organometallic Chem.,
2007,
21,
711-715
-
D. M. Chisholm, J. S. McIndoe, G. Bodizs, W. H. Ang, R. Scopelliti, P. J. Dyson,
Investigation into the formation of heteronuclear clusters of formula [{Ru6C(CO)16Ag2X}2]2- (X = Cl, Br or I),
J. Cluster Sci.,
2007,
18,
303-318
2006
-
Z. Fei, W. H. Ang, D. Zhao, R. Scopelliti, P. J. Dyson,
Complexation associated rearrangement of iminobiphosphines to diphosphinoamines,
Inorg. Chim. Acta.,
2006,
359,
2635-2643
-
W. H. Ang, E. Daldini, C. Scolaro, R. Scopelliti, L. Juillerat-Jeanneret, P. J. Dyson*,
Development of ruthenium arene anticancer drugs that resist hydrolysis,
Inorg. Chem.,
2006,
45,
9006-9013
-
Z. Fei, D. Kuang, D. Zhao, C. Klein, W. H. Ang, S. M. Zakeeruddin, M. Grätzel, P. J. Dyson,
A Supercooled Imidazolium Iodide Ionic Liquid as a Low-Viscosity Electrolyte for Dye-Sensitized Solar Cells,
Inorg. Chem.,
2006,
45,
10407-10409
-
Z. Fei, W. H. Ang, T. J. Geldbach, R. Scopelliti, P. J. Dyson,
Ionic Solid-State Dimers and Polymers Derived from Imidazolium Dicarboxylic Acids,
Chem. Eur J.,
2006,
12,
4014-4020
-
W. H. Ang, P. J. Dyson*,
Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy,
Eur. J. Inorg. Chem.,
2006,
20,
4003-4018
-
A. Dorcier, W. H. Ang, S. Bolaño, L. Gonsalvi, L. Juillerat-Jeannerat, G. Laurenczy, M. Peruzzini, A. D. Phillips, F. Zanobini, P. J. Dyson*,
In vitro evaluation of rhodium and osmium RAPTA analogues: the case for organometallic anticancer drugs not based on ruthenium,
Organometallics,
2006,
25,
4090-4096
-
Z. Fei, D. Zhao, W. H. Ang, P. J. Dyson,
A Strategy for the Synthesis of Transition-Metal Nanoparticles and their Transfer between Liquid Phases,
Small,
2006,
2,
879-883
2005
-
W. H. Ang, S. Pilet, R. Scopelliti, F. Bussy, L. Juillerat-Jeanneret*, P. J. Dyson*,
Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake,
J. Med Chem.,
2005,
48,
8060-8069
-
W. H. Ang, I. Khalaila, C. S. Allardyce, L. Juillerat-Jeanneret, P. J. Dyson*,
Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance,
J. Am. Chem. Soc.,
2005,
127,
1382-1383